Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare Biotechnology

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > It’s so OVER!!!!! :’(

<< Previous

Bullboard Posts

Next >>

Comment by Mil_Man54on Aug 10, 2020 11:57am

230 Views

Post# 31387667

RE:It’s so OVER!!!!! :’(

RE:Thank you DR RAZA Ouch Gabbo..looks like you're down $92K.....that's gotta hurt....luckily you're not using real money.....when you use your phone to call your broker....does the cow say "moo".....LOL GreatGabbo wrote: 8 pennies lets GO :D 2% gain on my 2.5MILLION DOLLARS = $50,000 this company will be HUGE

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks